Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Apr 14, 2026

ProShares Ultra Semiconductors (USD): Leveraging the AI-Driven Boom in U.S. Chips

Key Takeaways

  • Explosive AI infrastructure demand projected to drive global semiconductor sales to $975 billion in 2026, a 26% increase, heavily favoring USD's leveraged exposure to U.S. chip leaders.
  • USD's 2x daily leverage to the Dow Jones U.S. Semiconductors Index amplifies opportunities from top holdings like NVDA and AVGO amid rising AI chip revenues nearing $500 billion.
  • Portfolio concentration in semiconductors offers high growth potential but heightens risks from cyclical downturns, supply chain disruptions, and trade tensions.
  • Fund flows show volatility with recent net outflows, yet AUM remains robust at nearly $2 billion, signaling sustained trader interest in short-term tactical plays.
  • Upcoming catalysts include hyperscaler capex surges, memory price inflation, and Q2 2026 earnings from key holdings, potentially boosting index performance.
  • Structural leverage suits active traders but demands caution due to daily reset compounding effects over multi-day holds.

Understanding USD's Portfolio and Leveraged Strategy

The ProShares Ultra Semiconductors (USD) ETF aims to deliver daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors Index. In my analysis, this leveraged approach relies on derivatives like swaps to provide amplified exposure to U.S. companies in the semiconductors subsector, including producers, distributors, and equipment makers for chips and related products.

Looking at the top holdings, there's a clear emphasis on AI and high-performance computing leaders: NVDA at around 21-26%, AVGO at 8-9%, and MU at 2-4%, with others like AMD, Applied Materials, and Lam Research. The sector allocation is 100% technology, focused squarely on semiconductors, with U.S.-centric geographic exposure. Cash equivalents and Treasury bills serve as collateral for the swaps.

With a 0.95% expense ratio and nearly $2 billion in assets under management (AUM), USD is well-positioned for magnified gains from sector upswings driven by AI data centers, edge computing, and 5G/6G advancements. That said, the daily leverage reset means long-term holds can deviate significantly from 2x index returns due to volatility and compounding—one thing that stands out when reviewing leveraged products like this.

Key Catalysts on the Horizon

From what I see, several developments could significantly influence USD's path forward. Hyperscaler capital expenditures (capex) on AI infrastructure, led by firms like Microsoft and Google, are accelerating, with AI chip demand pushing revenues toward $500 billion in 2026. This directly benefits top holdings like NVDA and AVGO, potentially lifting the underlying index.

Memory market tightness, or "memflation," is expected to drive $200 billion in revenues, aiding MU and others amid high-bandwidth memory (HBM) shortages for AI. Q1-Q2 2026 earnings from semiconductor leaders will provide visibility on order backlogs and guidance. I also checked this using Tickeron’s AI Screener to see how these holdings compare within the industry.

The Federal Reserve's interest rate trajectory remains pivotal; potential cuts could ease borrowing costs for capex-heavy chipmakers, while persistent inflation might delay easing and pressure valuations. U.S.-China trade policies, including tariffs or export controls, pose risks to supply chains but could favor domestic U.S. firms in USD's index. Index rebalancings in March, June, September, and December may shift weights toward high performers.

Semiconductor Sector, Index, and Broader Macro Outlook

The Dow Jones U.S. Semiconductors Index, which USD tracks at 2x, stands to gain from a semiconductor sector forecasted for 26% growth to $975 billion in 2026, propelled by AI infrastructure, data center expansions, and memory demand. Generative AI chips could claim half of sales, underscoring the index's alignment with these megatrends.

Macro factors like moderating inflation and Fed rate cuts would support equity valuations and capex, while economic growth above 3% globally sustains tech spending. However, the sector's cyclicality introduces volatility; automotive and consumer electronics recovery lags, and geopolitical tensions—particularly U.S.-China trade—could disrupt foundry access. USD's leverage magnifies these sensitivities, thriving in bull markets but vulnerable to downturns. This is important because it highlights why I'm watching the index closely for tactical opportunities.

Insights from Tickeron’s Trend Prediction Engine

In my research process, I rely on tools like Tickeron’s Trend Prediction Engine, an AI-powered forecasting tool that helps identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It spots developing trends, evaluates possible breakouts or reversals, and covers a wide range of tradable instruments with searchable prediction categories, historical context, and alerts. For something as volatile as semiconductors, it provides timely insights into potential trajectory changes—I've found it particularly useful for ETFs like USD when assessing short-term momentum. If you're tracking these trends, exploring the Trend Prediction Engine can sharpen your strategy without the guesswork.

Long-Term Outlook and Enduring Sector Trends

Over the longer term, USD's prospects rest on semiconductors' central role in AI proliferation, projected to sustain industry growth toward $2 trillion by 2036. Technology adoption in data centers, autonomous vehicles, and IoT will bolster demand for advanced nodes and packaging. Demographic shifts toward digital economies and economic cycles favoring capex in recoveries further support the sector.

Interest rate normalization post-AI boom could temper multiples, but structural shifts like onshoring and CHIPS Act incentives enhance U.S.-focused resilience. Major holdings like NVDA and AVGO are poised for enduring AI leadership, though competition from custom silicon and memory oversupply risks loom. In my view, USD's leveraged positioning amplifies these themes effectively for tactical allocation amid evolving market structures.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: USD

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


Momentum Indicator for USD turns positive, indicating new upward trend

USD saw its Momentum Indicator move above the 0 level on September 17, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned positive. In 82 of the 85 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for USD just turned positive on September 18, 2026. Looking at past instances where USD's MACD turned positive, the stock continued to rise in 46 of 49 cases over the following month. The odds of a continued upward trend are 90%.

USD moved above its 50-day moving average on September 18, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for USD crossed bullishly above the 50-day moving average on September 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +5.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where USD advanced for three days, in 341 of 363 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where USD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

USD broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for USD entered a downward trend on September 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Lam Research Corp (NASDAQ:LRCX), Applied Materials (NASDAQ:AMAT), Texas Instruments (NASDAQ:TXN), KLA Corporation (NASDAQ:KLAC), Marvell Technology (NASDAQ:MRVL).

Industry description

The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Dow Jones U.S. SemiconductorsSM Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the stock performance of U.S. companies in the semiconductors sub-sector. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

Market Cap

The average market capitalization across the ProShares Ultra Semiconductors (USD) ETF is 320.35B. The market cap for tickers in the group ranges from 4.08B to 5.53T. NVDA holds the highest valuation in this group at 5.53T. The lowest valued company is ENPH at 4.08B.

High and low price notable news

The average weekly price growth across all stocks in the ProShares Ultra Semiconductors (USD) ETF was 9%. For the same ETF, the average monthly price growth was 16%, and the average quarterly price growth was 81%. MTSI experienced the highest price growth at 18%, while CBRS experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the ProShares Ultra Semiconductors (USD) ETF was -8%. For the same stocks of the ETF, the average monthly volume growth was -7% and the average quarterly volume growth was -63%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 68
P/E Growth Rating: 40
Price Growth Rating: 36
SMR Rating: 58
Profit Risk Rating: 56
Seasonality Score: 26 (-100 ... +100)
View a ticker or compare two or three
USD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Leveraged Equity
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.